/

Empresas

Ka

No verificado

Kashiv BioSciences, LLC and Amneal Pharmaceuticals, Inc. and Alvotech and Advanz Pharma

Sobre qué escribimos

BiotecnologíaFarmacéuticaHigiene alimentariaIndustriaVIH, SIDA y enfermedades autoinmunes

1 Comunicados de prensa

Ver todos los comunicados de prensa

06/10/2025

Salud

Higiene alimentaria

VIH, SIDA y enfermedades autoinmunes

Sanidad

Farmacéutica

Biotecnología

Industria

Kashiv Biosciences Announces Submission of Biologics License Application to U.S. FDA and Acceptance of Market Authorization Application by European Medicines Agency for ADL-018, a Proposed Biosimilar to XOLAIR® (omalizumab)

Fuente

Kashiv BioSciences, LLC and Amneal Pharmaceuticals, Inc. and Alvotech and Advanz Pharma

Editor

1.00

0

Seguidores

0

Compatibilidad

0